TGFB1 and systemic lupus erythematosus: Thus, this work demonstrated that low-dose tolerance with the conserved histone autoepitopes durably ameliorates the regulatory defect in SLE by inducing TGF-β producing Treg cells, and without causing adverse side effects such as, generalized immunosuppression or allergic/anaphylactic reactions (Figures 2 and 3).